ARTICLE | Clinical News
AMAP102: Phase IIa data
November 10, 2014 8:00 AM UTC
Top-line data from a double-blind Phase IIa trial in 116 patients with mild to moderate OA of the knee, either with or without hand OA, showed that AMAP102 missed the primary endpoint of reducing WOMA...